Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Rare Disease Drug market report explains the definition, types, applications, major countries, and major players of the Rare Disease Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Biogen Inc
Eisai Co Ltd
Pfizer Inc
Novo Nordisk A/S
ProQR
AstraZeneca
Amgen Inc
Deciphera
Daiichi Sankyo Company Limited
Bristol-Myers Squibb Company
Merck & Co Inc
Bayer AG
Sanofi SA
Eli Lilly and Company
Atara Biotherapeutics
Shire
F Hoffmann-La Roche Ltd
Johnson & Johnson
Novartis AG
Alexion Pharmaceuticals Inc
GlaxoSmithKline
Celgene Corporation
By Type:
>1‰
065‰～1‰
<01‰
By End-User:
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Rare Disease Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Rare Disease Drug Outlook to 2028- Original Forecasts
-
2.2 Rare Disease Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Rare Disease Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Rare Disease Drug Market- Recent Developments
-
6.1 Rare Disease Drug Market News and Developments
-
6.2 Rare Disease Drug Market Deals Landscape
7 Rare Disease Drug Raw Materials and Cost Structure Analysis
-
7.1 Rare Disease Drug Key Raw Materials
-
7.2 Rare Disease Drug Price Trend of Key Raw Materials
-
7.3 Rare Disease Drug Key Suppliers of Raw Materials
-
7.4 Rare Disease Drug Market Concentration Rate of Raw Materials
-
7.5 Rare Disease Drug Cost Structure Analysis
-
7.5.1 Rare Disease Drug Raw Materials Analysis
-
7.5.2 Rare Disease Drug Labor Cost Analysis
-
7.5.3 Rare Disease Drug Manufacturing Expenses Analysis
8 Global Rare Disease Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Rare Disease Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Rare Disease Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Rare Disease Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Rare Disease Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global >1‰ Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 065‰～1‰ Consumption and Growth Rate (2017-2022)
-
9.1.3 Global <01‰ Consumption and Growth Rate (2017-2022)
-
9.2 Global Rare Disease Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Speciality Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Retail pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Rare Disease Drug Market Analysis and Outlook till 2022
-
10.1 Global Rare Disease Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Rare Disease Drug Consumption (2017-2022)
-
10.2.2 Canada Rare Disease Drug Consumption (2017-2022)
-
10.2.3 Mexico Rare Disease Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Rare Disease Drug Consumption (2017-2022)
-
10.3.2 UK Rare Disease Drug Consumption (2017-2022)
-
10.3.3 Spain Rare Disease Drug Consumption (2017-2022)
-
10.3.4 Belgium Rare Disease Drug Consumption (2017-2022)
-
10.3.5 France Rare Disease Drug Consumption (2017-2022)
-
10.3.6 Italy Rare Disease Drug Consumption (2017-2022)
-
10.3.7 Denmark Rare Disease Drug Consumption (2017-2022)
-
10.3.8 Finland Rare Disease Drug Consumption (2017-2022)
-
10.3.9 Norway Rare Disease Drug Consumption (2017-2022)
-
10.3.10 Sweden Rare Disease Drug Consumption (2017-2022)
-
10.3.11 Poland Rare Disease Drug Consumption (2017-2022)
-
10.3.12 Russia Rare Disease Drug Consumption (2017-2022)
-
10.3.13 Turkey Rare Disease Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Rare Disease Drug Consumption (2017-2022)
-
10.4.2 Japan Rare Disease Drug Consumption (2017-2022)
-
10.4.3 India Rare Disease Drug Consumption (2017-2022)
-
10.4.4 South Korea Rare Disease Drug Consumption (2017-2022)
-
10.4.5 Pakistan Rare Disease Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Rare Disease Drug Consumption (2017-2022)
-
10.4.7 Indonesia Rare Disease Drug Consumption (2017-2022)
-
10.4.8 Thailand Rare Disease Drug Consumption (2017-2022)
-
10.4.9 Singapore Rare Disease Drug Consumption (2017-2022)
-
10.4.10 Malaysia Rare Disease Drug Consumption (2017-2022)
-
10.4.11 Philippines Rare Disease Drug Consumption (2017-2022)
-
10.4.12 Vietnam Rare Disease Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Rare Disease Drug Consumption (2017-2022)
-
10.5.2 Colombia Rare Disease Drug Consumption (2017-2022)
-
10.5.3 Chile Rare Disease Drug Consumption (2017-2022)
-
10.5.4 Argentina Rare Disease Drug Consumption (2017-2022)
-
10.5.5 Venezuela Rare Disease Drug Consumption (2017-2022)
-
10.5.6 Peru Rare Disease Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Rare Disease Drug Consumption (2017-2022)
-
10.5.8 Ecuador Rare Disease Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Rare Disease Drug Consumption (2017-2022)
-
10.6.2 Kuwait Rare Disease Drug Consumption (2017-2022)
-
10.6.3 Oman Rare Disease Drug Consumption (2017-2022)
-
10.6.4 Qatar Rare Disease Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Rare Disease Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Rare Disease Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Rare Disease Drug Consumption (2017-2022)
-
10.7.2 South Africa Rare Disease Drug Consumption (2017-2022)
-
10.7.3 Egypt Rare Disease Drug Consumption (2017-2022)
-
10.7.4 Algeria Rare Disease Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Rare Disease Drug Consumption (2017-2022)
-
10.8.2 New Zealand Rare Disease Drug Consumption (2017-2022)
11 Global Rare Disease Drug Competitive Analysis
-
11.1 Biogen Inc
-
11.1.1 Biogen Inc Company Details
-
11.1.2 Biogen Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Biogen Inc Rare Disease Drug Main Business and Markets Served
-
11.1.4 Biogen Inc Rare Disease Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Eisai Co Ltd
-
11.2.1 Eisai Co Ltd Company Details
-
11.2.2 Eisai Co Ltd Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Eisai Co Ltd Rare Disease Drug Main Business and Markets Served
-
11.2.4 Eisai Co Ltd Rare Disease Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Pfizer Inc
-
11.3.1 Pfizer Inc Company Details
-
11.3.2 Pfizer Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Pfizer Inc Rare Disease Drug Main Business and Markets Served
-
11.3.4 Pfizer Inc Rare Disease Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Novo Nordisk A/S
-
11.4.1 Novo Nordisk A/S Company Details
-
11.4.2 Novo Nordisk A/S Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Novo Nordisk A/S Rare Disease Drug Main Business and Markets Served
-
11.4.4 Novo Nordisk A/S Rare Disease Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 ProQR
-
11.5.1 ProQR Company Details
-
11.5.2 ProQR Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 ProQR Rare Disease Drug Main Business and Markets Served
-
11.5.4 ProQR Rare Disease Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 AstraZeneca
-
11.6.1 AstraZeneca Company Details
-
11.6.2 AstraZeneca Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 AstraZeneca Rare Disease Drug Main Business and Markets Served
-
11.6.4 AstraZeneca Rare Disease Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Amgen Inc
-
11.7.1 Amgen Inc Company Details
-
11.7.2 Amgen Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Amgen Inc Rare Disease Drug Main Business and Markets Served
-
11.7.4 Amgen Inc Rare Disease Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Deciphera
-
11.8.1 Deciphera Company Details
-
11.8.2 Deciphera Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Deciphera Rare Disease Drug Main Business and Markets Served
-
11.8.4 Deciphera Rare Disease Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Daiichi Sankyo Company Limited
-
11.9.1 Daiichi Sankyo Company Limited Company Details
-
11.9.2 Daiichi Sankyo Company Limited Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Daiichi Sankyo Company Limited Rare Disease Drug Main Business and Markets Served
-
11.9.4 Daiichi Sankyo Company Limited Rare Disease Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Bristol-Myers Squibb Company
-
11.10.1 Bristol-Myers Squibb Company Company Details
-
11.10.2 Bristol-Myers Squibb Company Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Bristol-Myers Squibb Company Rare Disease Drug Main Business and Markets Served
-
11.10.4 Bristol-Myers Squibb Company Rare Disease Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Merck & Co Inc
-
11.11.1 Merck & Co Inc Company Details
-
11.11.2 Merck & Co Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Merck & Co Inc Rare Disease Drug Main Business and Markets Served
-
11.11.4 Merck & Co Inc Rare Disease Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Bayer AG
-
11.12.1 Bayer AG Company Details
-
11.12.2 Bayer AG Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Bayer AG Rare Disease Drug Main Business and Markets Served
-
11.12.4 Bayer AG Rare Disease Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Sanofi SA
-
11.13.1 Sanofi SA Company Details
-
11.13.2 Sanofi SA Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Sanofi SA Rare Disease Drug Main Business and Markets Served
-
11.13.4 Sanofi SA Rare Disease Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Eli Lilly and Company
-
11.14.1 Eli Lilly and Company Company Details
-
11.14.2 Eli Lilly and Company Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Eli Lilly and Company Rare Disease Drug Main Business and Markets Served
-
11.14.4 Eli Lilly and Company Rare Disease Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Atara Biotherapeutics
-
11.15.1 Atara Biotherapeutics Company Details
-
11.15.2 Atara Biotherapeutics Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Atara Biotherapeutics Rare Disease Drug Main Business and Markets Served
-
11.15.4 Atara Biotherapeutics Rare Disease Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Shire
-
11.16.1 Shire Company Details
-
11.16.2 Shire Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Shire Rare Disease Drug Main Business and Markets Served
-
11.16.4 Shire Rare Disease Drug Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 F Hoffmann-La Roche Ltd
-
11.17.1 F Hoffmann-La Roche Ltd Company Details
-
11.17.2 F Hoffmann-La Roche Ltd Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 F Hoffmann-La Roche Ltd Rare Disease Drug Main Business and Markets Served
-
11.17.4 F Hoffmann-La Roche Ltd Rare Disease Drug Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Johnson & Johnson
-
11.18.1 Johnson & Johnson Company Details
-
11.18.2 Johnson & Johnson Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Johnson & Johnson Rare Disease Drug Main Business and Markets Served
-
11.18.4 Johnson & Johnson Rare Disease Drug Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Novartis AG
-
11.19.1 Novartis AG Company Details
-
11.19.2 Novartis AG Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Novartis AG Rare Disease Drug Main Business and Markets Served
-
11.19.4 Novartis AG Rare Disease Drug Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Alexion Pharmaceuticals Inc
-
11.20.1 Alexion Pharmaceuticals Inc Company Details
-
11.20.2 Alexion Pharmaceuticals Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Alexion Pharmaceuticals Inc Rare Disease Drug Main Business and Markets Served
-
11.20.4 Alexion Pharmaceuticals Inc Rare Disease Drug Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 GlaxoSmithKline
-
11.21.1 GlaxoSmithKline Company Details
-
11.21.2 GlaxoSmithKline Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 GlaxoSmithKline Rare Disease Drug Main Business and Markets Served
-
11.21.4 GlaxoSmithKline Rare Disease Drug Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Celgene Corporation
-
11.22.1 Celgene Corporation Company Details
-
11.22.2 Celgene Corporation Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Celgene Corporation Rare Disease Drug Main Business and Markets Served
-
11.22.4 Celgene Corporation Rare Disease Drug Product Portfolio
-
11.22.5 Recent Research and Development Strategies
12 Global Rare Disease Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Rare Disease Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global >1‰ Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global 065‰～1‰ Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global <01‰ Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Rare Disease Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Speciality Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Retail pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Rare Disease Drug Market Analysis and Outlook to 2028
-
13.1 Global Rare Disease Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Rare Disease Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Rare Disease Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.5 France Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Rare Disease Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.3 India Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Rare Disease Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Rare Disease Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Rare Disease Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Rare Disease Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Rare Disease Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Rare Disease Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Rare Disease Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Rare Disease Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Rare Disease Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Rare Disease Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Rare Disease Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Rare Disease Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Rare Disease Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Rare Disease Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Rare Disease Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Rare Disease Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Rare Disease Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Rare Disease Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Rare Disease Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Rare Disease Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Rare Disease Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Rare Disease Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Rare Disease Drug
-
Figure of Rare Disease Drug Picture
-
Table Global Rare Disease Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Rare Disease Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global >1‰ Consumption and Growth Rate (2017-2022)
-
Figure Global 065‰～1‰ Consumption and Growth Rate (2017-2022)
-
Figure Global <01‰ Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Speciality Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Rare Disease Drug Consumption by Country (2017-2022)
-
Table North America Rare Disease Drug Consumption by Country (2017-2022)
-
Figure United States Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Rare Disease Drug Consumption by Country (2017-2022)
-
Figure Germany Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure France Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Rare Disease Drug Consumption by Country (2017-2022)
-
Figure China Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure India Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Table South America Rare Disease Drug Consumption by Country (2017-2022)
-
Figure Brazil Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Rare Disease Drug Consumption by Country (2017-2022)
-
Figure Bahrain Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Rare Disease Drug Consumption by Country (2017-2022)
-
Figure Nigeria Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Rare Disease Drug Consumption by Country (2017-2022)
-
Figure Australia Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Rare Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Biogen Inc Company Details
-
Table Biogen Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Inc Rare Disease Drug Main Business and Markets Served
-
Table Biogen Inc Rare Disease Drug Product Portfolio
-
Table Eisai Co Ltd Company Details
-
Table Eisai Co Ltd Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Co Ltd Rare Disease Drug Main Business and Markets Served
-
Table Eisai Co Ltd Rare Disease Drug Product Portfolio
-
Table Pfizer Inc Company Details
-
Table Pfizer Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Rare Disease Drug Main Business and Markets Served
-
Table Pfizer Inc Rare Disease Drug Product Portfolio
-
Table Novo Nordisk A/S Company Details
-
Table Novo Nordisk A/S Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk A/S Rare Disease Drug Main Business and Markets Served
-
Table Novo Nordisk A/S Rare Disease Drug Product Portfolio
-
Table ProQR Company Details
-
Table ProQR Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ProQR Rare Disease Drug Main Business and Markets Served
-
Table ProQR Rare Disease Drug Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Rare Disease Drug Main Business and Markets Served
-
Table AstraZeneca Rare Disease Drug Product Portfolio
-
Table Amgen Inc Company Details
-
Table Amgen Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Rare Disease Drug Main Business and Markets Served
-
Table Amgen Inc Rare Disease Drug Product Portfolio
-
Table Deciphera Company Details
-
Table Deciphera Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Deciphera Rare Disease Drug Main Business and Markets Served
-
Table Deciphera Rare Disease Drug Product Portfolio
-
Table Daiichi Sankyo Company Limited Company Details
-
Table Daiichi Sankyo Company Limited Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Company Limited Rare Disease Drug Main Business and Markets Served
-
Table Daiichi Sankyo Company Limited Rare Disease Drug Product Portfolio
-
Table Bristol-Myers Squibb Company Company Details
-
Table Bristol-Myers Squibb Company Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Rare Disease Drug Main Business and Markets Served
-
Table Bristol-Myers Squibb Company Rare Disease Drug Product Portfolio
-
Table Merck & Co Inc Company Details
-
Table Merck & Co Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Rare Disease Drug Main Business and Markets Served
-
Table Merck & Co Inc Rare Disease Drug Product Portfolio
-
Table Bayer AG Company Details
-
Table Bayer AG Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Rare Disease Drug Main Business and Markets Served
-
Table Bayer AG Rare Disease Drug Product Portfolio
-
Table Sanofi SA Company Details
-
Table Sanofi SA Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Rare Disease Drug Main Business and Markets Served
-
Table Sanofi SA Rare Disease Drug Product Portfolio
-
Table Eli Lilly and Company Company Details
-
Table Eli Lilly and Company Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Rare Disease Drug Main Business and Markets Served
-
Table Eli Lilly and Company Rare Disease Drug Product Portfolio
-
Table Atara Biotherapeutics Company Details
-
Table Atara Biotherapeutics Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Atara Biotherapeutics Rare Disease Drug Main Business and Markets Served
-
Table Atara Biotherapeutics Rare Disease Drug Product Portfolio
-
Table Shire Company Details
-
Table Shire Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Rare Disease Drug Main Business and Markets Served
-
Table Shire Rare Disease Drug Product Portfolio
-
Table F Hoffmann-La Roche Ltd Company Details
-
Table F Hoffmann-La Roche Ltd Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Rare Disease Drug Main Business and Markets Served
-
Table F Hoffmann-La Roche Ltd Rare Disease Drug Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Rare Disease Drug Main Business and Markets Served
-
Table Johnson & Johnson Rare Disease Drug Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Rare Disease Drug Main Business and Markets Served
-
Table Novartis AG Rare Disease Drug Product Portfolio
-
Table Alexion Pharmaceuticals Inc Company Details
-
Table Alexion Pharmaceuticals Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alexion Pharmaceuticals Inc Rare Disease Drug Main Business and Markets Served
-
Table Alexion Pharmaceuticals Inc Rare Disease Drug Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Rare Disease Drug Main Business and Markets Served
-
Table GlaxoSmithKline Rare Disease Drug Product Portfolio
-
Table Celgene Corporation Company Details
-
Table Celgene Corporation Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Rare Disease Drug Main Business and Markets Served
-
Table Celgene Corporation Rare Disease Drug Product Portfolio
-
Figure Global >1‰ Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 065‰～1‰ Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global <01‰ Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Speciality Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rare Disease Drug Consumption Forecast by Country (2022-2028)
-
Table North America Rare Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Rare Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Rare Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure China Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Rare Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Rare Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Rare Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Rare Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
